John C. Martin, CEO of Gilead Sciences, a pharmaceutical company, has set a price of $1,000/pill in the US for the newly-approved drug Sovaldi, which has recently been proven to cure Hepatitis C. The full treatment would require 84 pills, which in combination with other drugs would raise the price of a cure to around… Continua a leggere GILEAD SCIENCES: $84,000 OR YOUR LIFE